News & Announcements
First Criminal Conviction Secured with Next-Gen Forensic DNA Technology
San Diego, June 4, 2019—Verogen announced today that its DNA sequencing technology played a pivotal role in a recent court case in the Netherlands. This marks the first time that evidence generated with so-called “next generation” or massively parallel sequencing (MPS) has been used to secure a conv [...]
Cellmark and Verogen Collaborate to Make the Next Generation of Forensic DNA Analysis Available to UK Police
San Diego, May 8, 2019—Cellmark Forensic Services and Verogen have signed a collaboration agreement to establish Cellmark as a United Kingdom (UK) center of excellence for forensic next generation sequencing (NGS), also known as massively parallel DNA sequencing (MPS). Verogen, the leading provider [...]
Medpricer Signs Deal with Texas Children’s Hospital for Purchased Services Sourcing
May 8th, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the health care industry, announced today that Texas Children’s Hospital chose its mSource software platform to centralize its purchased service sourcing efforts. Texas Children’s H [...]
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
April 30, 2019 (Madison, WI): Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG; OTCQX: RHHBY) to commercialize its proprietary chemical synthesis technology for drug development. The company also completed a Series A financin [...]
Intermountain Healthcare Strikes Deal with Medpricer
GUILFORD, CONN. AND WALNUT CREEK, CALIF. (PRWEB) APRIL 22, 2019 Medpricer, the leading purchased services cost management solution for the healthcare industry, announced today Intermountain Healthcare has joined its customer roster. Through this partnership, Intermountain Healthcare will have access [...]
Clinical Solutions to Provide Clients Products & Services to Accelerate the Clinical and Commercial Development of Gene and Cell Therapies
Vancouver, British Columbia– Precision NanoSystems (PNI), a biotechnology company pioneering innovative solutions for the development of genetic nanomedicines used in oncology, rare disease and infectious disease, announced today the launch of its Clinical Solutions service. PNI is offering this ne [...]
Akoya Biosciences Appoints Joseph Driscoll as Chief Financial Officer
MENLO PARK, Calif.--Akoya Biosciences, Inc., today announced the appointment of Joseph Driscoll as Chief Financial Officer. Mr. Driscoll joins Akoya with more than 30 years of financial leadership experience and a proven track record of driving growth and increasing company valuations. “I am delight [...]